Agreement and utility of coded primary and secondary care data for long-term follow-up of clinical trial outcomes.
Wang A. et al, (2025), BMC Med Res Methodol, 25
Implementation, Processes and Outcomes of Advance Care Planning: A Culturally and Contextually Appropriate Programme Theory Developed in Chinese Long-Term Care Facilities
Zhou Y. et al, (2025), Health Expectations, 28
Developing prediction models for electrolyte abnormalities in patients indicated for antihypertensive therapy: evidence-based treatment and monitoring recommendations
Wang A. et al, (2025), Journal of Hypertension
Risk Stratification in Older Intensively Treated Patients With AML.
Versluis J. et al, (2024), J Clin Oncol
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial
Sheppard JP. et al, (2024), The Lancet Healthy Longevity, 5, e563 - e573
Effect of antihypertensive deprescribing on serious adverse events, mortality, and cardiovascular disease: Long-term follow-up of the OPTiMISE randomised controlled trial
SHEPPARD J. et al, (2024), The Lancet Healthy Longevity
EFFECT OF ANTIHYPERTENSIVE DEPRESCRIBING ON SERIOUS ADVERSE EVENTS, MORTALITY, AND CARDIOVASCULAR DISEASE: LONG-TERM FOLLOW-UP OF THE OPTIMISE RANDOMISED CONTROLLED TRIAL
Sheppard J. et al, (2024), JOURNAL OF HYPERTENSION, 42
FALLS AND OTHER SERIOUS ADVERSE EVENT RISKS OF ANTIHYPERTENSIVE MEDICATION THERAPY IN THE PATIENTS WITH DEMENTIA
Fujiwara T. et al, (2023), JOURNAL OF HUMAN HYPERTENSION, 37, 24 - 24
PREDITING THE RISK OF FRACTURE ASSOCIATED WITH ANTIHYPERTENSIVE TREATMENT: DEVELOPMENT OF THE STRATIFY-FRACTURE PREDICTION MODEL
Wang A. et al, (2023), JOURNAL OF HUMAN HYPERTENSION, 37, 11 - 11
PREDITING THE RISK OF FRACTURE ASSOCIATED WITH ANTIHYPERTENSIVE TREATMENT: DEVELOPMENT OF THE STRATIFY-FRACTURE PREDICTION MODEL
Wang A. et al, (2023), JOURNAL OF HYPERTENSION, 41, E3 - E3
Surveillance of people with previously successfully treated diabetic macular oedema and proliferative diabetic retinopathy by trained ophthalmic graders: cost analysis from the EMERALD study.
Maredza M. et al, (2022), Br J Ophthalmol, 106, 1549 - 1554
Mechanisms and contextual influences on the implementation of advance care planning for older people in long-term care facilities: A realist review
Zhou Y. et al, (2022), International Journal of Nursing Studies, 104277 - 104277
Identifying risk factors of monoclonal gammopathy of undetermined significance (MGUS): a population-based study using data from the UK clinical practice research datalink (CPRD)
Koshiaris C. et al, (2022), CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 22, S131 - S131
Study of Peri-Articular Anaesthetic for Replacement of the Knee (SPAARK): statistical analysis plan for a randomised controlled trial assessing the effectiveness of peri-articular liposomal bupivacaine plus bupivacaine hydrochloride compared with bupivacaine hydrochloride alone
Stokes JR. et al, (2021), Trials, 22
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial
Hinks TSC. et al, (2021), The Lancet Respiratory Medicine, 9, 1130 - 1140
Evaluation of a New Model of Care for People with Complications of Diabetic Retinopathy: The EMERALD Study (vol 128, pg 561, 2021)
Lois N. et al, (2021), OPHTHALMOLOGY, 128, 1117 - 1117